Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article.
Verlinden I, van den Hurk K, Clarijs R, Willig AP, Stallinga CMHA, Roemen GMJM, van den Oord JJ, Zur Hausen A, Speel EM, Winnepenninckx VJL. Verlinden I, et al. Among authors: van den oord jj, van den hurk k. Medicine (Baltimore). 2014 Dec;93(28):e285. doi: 10.1097/MD.0000000000000285. Medicine (Baltimore). 2014. PMID: 25526463 Free PMC article.
Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
van den Hurk K, Niessen HE, Veeck J, van den Oord JJ, van Steensel MA, Zur Hausen A, van Engeland M, Winnepenninckx VJ. van den Hurk K, et al. Among authors: van den oord jj, van steensel ma, van engeland m. Biochim Biophys Acta. 2012 Aug;1826(1):89-102. doi: 10.1016/j.bbcan.2012.03.011. Epub 2012 Mar 31. Biochim Biophys Acta. 2012. PMID: 22503822 Review.
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
Gao L, van den Hurk K, Moerkerk PTM, Goeman JJ, Beck S, Gruis NA, van den Oord JJ, Winnepenninckx VJ, van Engeland M, van Doorn R. Gao L, et al. Among authors: van den oord jj, van den hurk k, van doorn r, van engeland m. J Invest Dermatol. 2014 Dec;134(12):2957-2966. doi: 10.1038/jid.2014.270. Epub 2014 Jul 7. J Invest Dermatol. 2014. PMID: 24999589 Free article.
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.
Gao L, van den Hurk K, Nsengimana J, Laye JP, van den Oord JJ, Beck S, Gruis NA, Zoutman WH, van Engeland M, Newton-Bishop JA, Winnepenninckx VJ, van Doorn R. Gao L, et al. Among authors: van den oord jj, van den hurk k, van doorn r, van engeland m. J Invest Dermatol. 2015 Sep;135(9):2328-2331. doi: 10.1038/jid.2015.163. Epub 2015 Apr 28. J Invest Dermatol. 2015. PMID: 25918983 Free article. No abstract available.
Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.
van Kempen LC, van den Hurk K, Lazar V, Michiels S, Winnepenninckx V, Stas M, Spatz A, van den Oord JJ. van Kempen LC, et al. Among authors: van den oord jj, van den hurk k. Virchows Arch. 2012 Oct;461(4):441-8. doi: 10.1007/s00428-012-1309-9. Epub 2012 Sep 6. Virchows Arch. 2012. PMID: 22956368
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
van den Hurk K, Balint B, Toomey S, O'Leary PC, Unwin L, Sheahan K, McDermott EW, Murphy I, van den Oord JJ, Rafferty M, FitzGerald DM, Moran J, Cummins R, MacEneaney O, Kay EW, O'Brien CP, Finn SP, Heffron CC, Murphy M, Yela R, Power DG, Regan PJ, McDermott CM, O'Keeffe A, Orosz Z, Donnellan PP, Crown JP, Hennessy BT, Gallagher WM. van den Hurk K, et al. Among authors: van den oord jj. Melanoma Res. 2015 Jun;25(3):189-99. doi: 10.1097/CMR.0000000000000149. Melanoma Res. 2015. PMID: 25746038
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O, Laguna T, Joseph J, Dynoodt P, Aura C, Foth M, Cloots R, van den Hurk K, Balint B, Murphy IG, McDermott EW, Sheahan K, Jirström K, Nodin B, Mallya-Udupi G, van den Oord JJ, Gallagher WM, Esteller M. Wouters J, et al. Among authors: van den oord jj, van den hurk k. BMC Med. 2017 Jun 5;15(1):101. doi: 10.1186/s12916-017-0851-3. BMC Med. 2017. PMID: 28578692 Free PMC article.
Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.
Brinkhuizen T, van den Hurk K, Winnepenninckx VJ, de Hoon JP, van Marion AM, Veeck J, van Engeland M, van Steensel MA. Brinkhuizen T, et al. Among authors: van den hurk k, van steensel ma, van marion am, van engeland m. PLoS One. 2012;7(12):e51710. doi: 10.1371/journal.pone.0051710. Epub 2012 Dec 17. PLoS One. 2012. PMID: 23284750 Free PMC article.
Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria.
van den Elzen MT, van Os-Medendorp H, van den Brink I, van den Hurk K, Kouznetsova OI, Lokin ASHJ, Laheij-de Boer AM, Röckmann H, Bruijnzeel-Koomen CAFM, Knulst AC. van den Elzen MT, et al. Among authors: van den hurk k, van os medendorp h, van den brink i. Clin Transl Allergy. 2017 Feb 14;7:4. doi: 10.1186/s13601-017-0141-3. eCollection 2017. Clin Transl Allergy. 2017. PMID: 28289538 Free PMC article.
109 results